Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug

被引：1
|
作者：
Buiter, Hans J. C. [1 ]
Derijks, Luc [2 ]
Mulder, Chris J. J. [3 ]
机构：
[1] Univ Amsterdam, Med Ctr, Dept Clin Pharmacol & Pharm, Amsterdam, Netherlands
[2] Maxima Med Ctr, Dept Clin Pharm & Pharmacol, Veldhoven, Netherlands
[3] Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY | 2019年 / 26卷 / 05期
关键词：
Purine nucleoside analogues; cladribine; multiple sclerosis; subcutaneous; cost; drug; re-discovery; off-label; immune suppression; DMT;
D O I：
10.1136/ejhpharm-2019-002026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [41] Oral Cladribine and Fingolimod for Relapsing Multiple Sclerosis.
    Mann, Howard
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18): : 1738 - 1738
  • [42] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2011, 25 : 239 - 249
  • [43] CLADIN: CLADribine and INnate Immune responses in Multiple Sclerosis
    Sequeira, Richard
    Muscat, Andrea
    Stukey, Sian
    Minh, Viet
    Loftus, Naomi
    Voo, Veronica
    Fazzolari, Katherine
    Moss, Melinda
    Maltby, Vicki E.
    Sanfilippo, Paul
    Nguyen, Ai-Lan
    Wesselingh, Robb
    Seery, Nabil
    Nesbitt, Cassie
    Baker, Josephine
    Dwyer, Chris
    Taylor, Lisa
    Rath, Louise
    Van der Walt, Anneke
    Marriott, Mark
    Kalincik, Tomas
    Lechner-Scott, Jeannette
    O'Brien, Terence J.
    Butzkueven, Helmut
    Monif, Mastura
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (04) : 49 - 49
  • [44] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [45] CLADRIBINE IN TREATMENT OF CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS
    SIPE, JC
    ROMINE, JS
    KOZIOL, JA
    MCMILLAN, R
    ZYROFF, J
    BEUTLER, E
    LANCET, 1994, 344 (8914): : 9 - 13
  • [46] Cladribine tablets and multiple sclerosis: NICE technology appraisal
    Gaber, Tarek
    Shippen, Clare
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2018, 22 (01) : 5 - 6
  • [47] Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients
    Alchaki, Abdul Rahman
    Anadani, Nidhiben
    Cook, Stuart
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 28 - 29
  • [48] Cladribine as treatment of multiple sclerosis, real world experience
    Celius, E. G.
    Berg-Hansen, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 527 - 528
  • [49] Treatment of multiple sclerosis and other autoimmune diseases with cladribine
    Beutler, E
    Sipe, J
    Romine, J
    McMillan, R
    Zyroff, J
    Koziol, J
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 45 - 52
  • [50] Therapeutic Decision Making in a New Drug Era in Multiple Sclerosis
    Keegan, B. Mark
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 5 - 12
12345